论文部分内容阅读
目的:观察替吉奥胶囊对老年晚期胃癌的疗效和不良反应。方法:将100例老年晚期胃癌患者随机均分为试验组和对照组,试验组单纯口服替吉奥胶囊,对照组采用FOLFOX4化疗方案。结果:试验组完全缓解2例,部分缓解24例,总有效率为43.33%;对照组无完全缓解病例,部分缓解22例。总有效率为36.67%:试验组不良反应发生率明显较对照组低(P<0.05)。结论:替吉奥胶囊对老年晚期胃癌治疗可靠、毒副作用较轻,患者耐受性较好,适用于门诊给药并具药物经济学价值。
Objective: To observe the efficacy and adverse reactions of TIGO capsules for elderly patients with advanced gastric cancer. Methods: A total of 100 elderly patients with advanced gastric cancer were randomly divided into experimental group and control group. The experimental group was given oral gavage alone and the control group received FOLFOX4 chemotherapy. Results: In the experimental group, 2 cases were completely relieved, 24 cases partially relieved, and the total effective rate was 43.33%. There was no complete remission in the control group and 22 cases partial remission. The total effective rate was 36.67%: The incidence of adverse reactions in the experimental group was significantly lower than that in the control group (P <0.05). CONCLUSION: TEGO capsules are reliable for treatment of elderly patients with advanced gastric cancer, with less toxic side effects and better tolerability. They are suitable for outpatient administration and have the value of pharmacoeconomics.